Cargando…
Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands
BACKGROUND: In 2010 a Cochrane review confirmed that folic acid (FA) supplementation prevents the first- and second-time occurrence of neural tube defects (NTDs). At present some evidence from observational studies supports the hypothesis that FA supplementation can reduce the risk of all congenital...
Autores principales: | Bortolus, Renata, Blom, Fenneke, Filippini, Francesca, van Poppel, Mireille NM, Leoncini, Emanuele, de Smit, Denhard J, Benetollo, Pier Paolo, Cornel, Martina C, de Walle, Hermien EK, Mastroiacovo, Pierpaolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045958/ https://www.ncbi.nlm.nih.gov/pubmed/24884885 http://dx.doi.org/10.1186/1471-2393-14-166 |
Ejemplares similares
-
Efficacy of 4.0 mg versus 0.4 mg Folic Acid Supplementation on the Reproductive Outcomes: A Randomized Controlled Trial
por: Bortolus, Renata, et al.
Publicado: (2021) -
Folic Acid Supplementation and Preterm Birth: Results from Observational Studies
por: Mantovani, Elena, et al.
Publicado: (2014) -
Prevalence and determinants of preconception folic acid use: an Italian multicenter survey
por: Nilsen, Roy M., et al.
Publicado: (2016) -
Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008) -
Exploring the reach and program use of hello world, an email-based health promotion program for pregnant women in the Netherlands
por: van Dongen, Johanna M, et al.
Publicado: (2012)